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background
 
Two randomized trials have shown better outcomes with elective endovascular repair
of abdominal aortic aneurysms than with conventional open repair in the first month
after the procedure. We investigated whether this advantage is sustained beyond the
perioperative period.
 
methods
 
We conducted a multicenter, randomized trial comparing open repair with endovascular
repair in 351 patients who had received a diagnosis of abdominal aortic aneurysm of at
least 5 cm in diameter and who were considered suitable candidates for both techniques.
Survival after randomization was calculated with the use of Kaplan–Meier analysis and
compared with the use of the log-rank test on an intention-to-treat-basis.
 
results
 
Two years after randomization, the cumulative survival rates were 89.6 percent for
open repair and 89.7 percent for endovascular repair (difference, ¡0.1 percentage point;
95 percent confidence interval, ¡6.8 to 6.7 percentage points). The cumulative rates of
aneurysm-related death were 5.7 percent for open repair and 2.1 percent for endovascu-
lar repair (difference, 3.7 percentage points; 95 percent confidence interval, ¡0.5 to 7.9
percentage points). This advantage of endovascular repair over open repair was entire-
ly accounted for by events occurring in the perioperative period, with no significant dif-
ference in subsequent aneurysm-related mortality. The rate of survival free of moderate
or severe complications was also similar in the two groups at two years (at 65.9 percent
for open repair and 65.6 percent for endovascular repair; difference, 0.3 percentage
point; 95 percent confidence interval, ¡10.0 to 10.6 percentage points).
 
conclusions
 
The perioperative survival advantage with endovascular repair as compared with open
repair is not sustained after the first postoperative year.
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wo randomized trials have dem-
 
onstrated better outcomes with elective
endovascular repair of abdominal aortic
aneurysms than with conventional open repair in
the first month after the procedure.
 
1,2
 
 The reported
in-hospital mortality rates in these two trials were
4.6 percent and 6.0 percent for open repair and 1.6
percent and 1.2 percent for endovascular repair, re-
spectively. Although the relevance of a reduction in
perioperative risk should not be underestimated
from the patient’s perspective, the improvement
in early survival with the use of a less invasive tech-
nique is not surprising.
 
3
 
 Consequently, both reports
stressed the need for longer-term data before a de-
cision could be reached about which therapy is bet-
ter in patients who are suitable candidates for either
procedure.
Findings in uncontrolled long-term studies of
endovascular aneurysm repair have suggested that
the early advantage of endovascular over open repair
may not persist over time.
 
4,5
 
 Endovascular repair
appeared to be associated with higher rates of re-
intervention and complications as well as a con-
tinued risk of aneurysm rupture. The Dutch Ran-
domized Endovascular Aneurysm Management
(DREAM) trial was conducted to assess the rates of
death from any cause and complications in a multi-
center, randomized trial comparing elective open
and endovascular aneurysm repair.
 
study design and patients
 
The design and methods of the trial have been de-
scribed in detail elsewhere.
 
2,6
 
 In brief, patients re-
ferred to surgery clinics at 26 centers in the Nether-
lands and 4 centers in Belgium who had received a
diagnosis of an abdominal aortic aneurysm of at
least 5 cm in diameter and who were considered
suitable candidates for both techniques were ran-
domly assigned to undergo open or endovascular
repair after giving written informed consent. Ran-
domization was carried out centrally with the use
of a computer-generated permuted-block sequence
and stratified according to study center in blocks of
four patients.
The study was performed according to the prin-
ciples of the Declaration of Helsinki. The institu-
tional review boards of all participating hospitals
approved the protocol. The corresponding author
assumed full responsibility for the conduct of the
trial, had full access to all the data, and controlled
the decision to publish. The study was publicly
funded, and the sponsor had no role in the study
design.
 
data collection and follow-up
 
All data were submitted to the trial-coordination
center (Julius Center for Health Sciences and Pri-
mary Care, University Medical Center, Utrecht,
the Netherlands). Follow-up visits were scheduled
30 days and 6, 12, 18, and 24 months after the
procedure. Before hospital discharge and at each
follow-up visit, all patients underwent a physical
examination, which included calculation of the
ankle–brachial blood-pressure index; abdominal
helical computed tomographic angiography; and
abdominal color duplex ultrasonography. In addi-
tion, patients in the endovascular group underwent
plain abdominal radiography before hospital dis-
charge and 12 and 24 months postoperatively.
Data acquisition was stopped on March 1, 2005,
for this report. For all analyses, data on patients
were censored after their last follow-up visit. For
the crude survival analysis, however, reports on
vital status obtained at any time before the cutoff
date were also incorporated.
 
end points
 
The primary end point of the trial was a composite
of operative mortality and moderate or severe com-
plications, as discussed in the initial report on the
results of the trial.
 
2
 
 Mortality and complications at
two years were predetermined secondary end points
in the original trial design. The outcome events that
we analyzed were deaths from all causes, aneurysm-
related deaths, complications, and reinterventions.
The cause and exact date of death were deter-
mined by assessment of death certificates and by
contacting the physicians involved (surgeons and
general practitioners) and patients’ relatives if nec-
essary. Aneurysm-related death was defined as death
resulting from aneurysm rupture, graft infection,
or thrombosis; any death occurring within 30 days
after the original procedure or a reintervention; or
any death occurring more than 30 days after the
original procedure or a reintervention but during
the same admission.
Complications were classified and graded ac-
cording to the reporting standards of the Ad Hoc
Committee for Standardized Reporting Practices
in Vascular Surgery of the Society for Vascular Sur-
gery/International Society for Cardiovascular Sur-
gery.
 
7,8
 
 Three severity grades (mild, moderate, and
t
methods
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severe) were distinguished. Mild complications
were not considered in this analysis. A reinterven-
tion was defined as any surgical or endovascular
procedure performed after the primary aneurysm-
repair procedure and related to the aneurysm or
the primary procedure, including incisional her-
nia repairs but exclusive of procedures involving
superficial wound complications. An outcome
adjudication committee, consisting of five vascu-
lar surgeons, assessed the type and severity of
each complication and reintervention in a blinded
fashion and independently from each other. Dis-
agreements were resolved in a plenary consensus
meeting.
 
statistical analysis
 
All data were analyzed according to the intention-
to-treat principle. Kaplan–Meier analysis was used
to analyze survival and other end points, and differ-
ences between groups were compared with the use
of the log-rank test. Cox proportional-hazards re-
gression was used to estimate hazard ratios for the
analysis of reintervention rates. Means (±SD) were
used to describe continuous variables. Differences
between groups were compared with the use of the
Mann–Whitney U test for continuous variables and
Fisher’s exact test for proportions. All reported
P values are two-sided and are not adjusted for
multiple testing.
 
characteristics of the patients 
and treatment assignments
 
Between November 2000 and December 2003,
178 patients were randomly assigned to undergo
open repair and 173 to undergo endovascular repair.
Six patients did not undergo aneurysm repair after
randomization: four declined treatment (three as-
signed to open repair and one to endovascular re-
pair), one died from a ruptured abdominal aortic
aneurysm before undergoing open repair, and one
died from pneumonia before undergoing endovas-
cular repair. There were six crossovers: five patients
who were randomly assigned to undergo open re-
pair underwent endovascular repair, and one pa-
tient assigned to endovascular repair underwent
open repair. Overall, the operation was started ac-
cording to the randomized assignment in 96.6 per-
cent of patients (339 of 351).
The baseline characteristics of the patients are
given in Table 1. Demographic characteristics, the
prevalence of coexisting conditions, cardiovascular-
risk profiles, the distribution of American Society
of Anesthesiologists risk classes, and medication
use were similar in the two groups.
The median interval between randomization and
the procedure was 39 days in both the open-repair
group (range, 4 to 260) and the endovascular-
repair group (range, 1 to 183; P=0.76); 92.6 percent
results
 
* Plus–minus values are means ±SD. There were no significant differences be-
tween the groups. FEV
 
1
 
 denotes forced expiratory volume in one second, and 
ASA American Society of Anesthesiologists. The body-mass index is the weight 
in kilograms divided by the square of the height in meters. Because of round-
ing, not all percentages total 100.
† The Society for Vascular Surgery/International Society for Cardiovascular Sur-
gery (SVS/ISCVS) risk-factor score is calculated for eight domains, and scores 
for each domain can range from 0 (no risk factors) to 3 (severe risk factors).
 
7
 
 
Total scores can range from 0 to 24, with higher scores indicating greater risk.
‡ No information on the use of statins was available for six patients in the open-
 
repair group and four patients in the endovascular-repair group.
 
Table 1. Baseline Characteristics of the Patients.*
Characteristic
Open 
Repair
(N=178)
Endovascular 
Repair
(N=173)
 
Age — yr 69.6±6.8 70.7±6.6
Male sex — no. (%) 161 (90.4) 161 (93.1)
Mild, moderate, or severe SVS/ISCVS 
risk-factor score — %†
Diabetes mellitus 9.6 10.4
Tobacco use 55.1 64.2
Hypertension 54.5 58.4
Hyperlipidemia 52.6 47.0
Carotid artery disease 15.2 14.5
Cardiac disease 46.6 41.0
Renal disease 8.4 7.5
Pulmonary disease 18.5 27.7
Total SVS/ISCVS risk-factor score† 4.5±2.5 4.4±2.5
FEV
 
1
 
 — liters/sec 2.6±0.7 2.5±0.7
Body-mass index 26.6±4.1 26.3±3.4
ASA class — no. (%)
I (healthy status) 44 (24.7) 37 (21.4)
II (mild systemic disease) 110 (61.8) 122 (70.5)
III (severe systemic disease) 24 (13.5) 14 (8.1)
Medication use — no. (%)
Beta-blockers 92 (51.7) 76 (43.9)
Statins‡ 72 (41.9) 63 (37.3)
Antiplatelet agents 72 (40.4) 70 (40.5)
Angiotensin-converting–enzyme inhibitors 50 (28.1) 58 (33.5)
Calcium-channel blockers 32 (18.0) 30 (17.3)
Anticoagulants 27 (15.2) 20 (11.6)
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of patients (325 of 351) underwent aneurysm re-
pair within 3 months after randomization. The
mean duration of follow-up was 21 months in the
open-repair group (range, 0 to 39) and 22 months
in the endovascular-repair group (range, 1 to 42).
A total of 6 patients were lost to follow-up during
the first year (follow-up 98.3 percent complete) and
19 during the first two years (follow-up 94.6 percent
complete).
 
mortality
 
Two years after randomization, the cumulative sur-
vival rates were 89.6 percent for open repair and
89.7 percent for endovascular repair, for a difference
of ¡0.1 percentage point (95 percent confidence
interval, ¡6.8 to 6.7 percentage points; P=0.86)
(Fig. 1). The small but apparent survival advantage
in the first year after endovascular repair did not
reach statistical significance (P=0.15) and ap-
peared to be based entirely on a decreased rate of
in-hospital (perioperative) mortality.
There was one preoperative death and eight in-
hospital deaths in the open-repair group and one
preoperative and two in-hospital deaths in the endo-
vascular-repair group (Table 2). Taking into account
the patients who declined treatment (three in the
open-repair group and one in the endovascular-
repair group), there were 166 discharges after open
repair and 169 discharges after endovascular repair.
The causes of death are listed in Table 2. After dis-
charge, there were more deaths from cardiovascu-
lar causes in the endovascular-repair group than in
the open-repair group (six vs. three), although this
difference was not significant (P=0.50).
There was an unexplained cluster of deaths in
the endovascular-repair group approximately one
year after randomization (Fig. 1). None of these
deaths were considered to be aneurysm-related as
defined in the Methods section; two of the deaths
were due to heart failure, one to acute cardiac ar-
rest, one to stroke, and one to aspiration pneumo-
nia in a patient with metastatic carcinoma of the
bladder.
 
aneurysm-related mortality
 
The cumulative rates of aneurysm-related death two
years after randomization were 5.7 percent in the
open-repair group and 2.1 percent in the endovas-
cular-repair group, for a difference of 3.7 percent-
age points (95 percent confidence interval, ¡0.5 to
7.9 percentage points; P=0.05). The difference in
aneurysm-related mortality at two years was based
entirely on the difference in in-hospital (periopera-
tive) mortality. After discharge, only one additional
aneurysm-related death occurred in each group
(Table 2).
 
complications
 
Two years after randomization, the rates of survival
free of severe events were 80.6 percent for open
repair and 83.1 percent for endovascular repair, for
a difference of ¡2.5 percentage points (95 percent
confidence interval, ¡10.9 to 5.9 percentage points;
P=0.39) (Fig. 2). As with the data on aneurysm-
related mortality, the difference in the rate of sur-
vival free from severe events at two years was based
entirely on the difference in in-hospital events. The
rates of survival free of moderate or severe events
two years after randomization were 65.9 percent
for open repair and 65.6 percent for endovascular
repair, for a difference of 0.3 percentage point (95
percent confidence interval, ¡10.0 to 10.6 percent-
age points; P=0.88).
There were no documented postoperative aneu-
rysm ruptures. However, in two patients who died
after endovascular repair, the possibility of aneu-
rysm rupture was considered but not proved (Ta-
ble 2).
Kaplan–Meier estimates of the likelihood of free-
dom from reintervention are shown in Figure 3. In
the first nine months after randomization, the rate
of reintervention after endovascular repair was al-
 
Figure 1. Kaplan–Meier Estimates of Survival among Patients Assigned 
to Undergo Open or Endovascular Aneurysm Repair.
P=0.86
1.00
Pr
ob
ab
ili
ty
 o
f S
ur
vi
va
l
0.90
0.95
0.85
0.80
0
0 6 12 18 24
Endovascular repair
Open repair
Months after Randomization
No. at Risk
Open repair
Endovascular repair
97
98
133
134
160
163
164
166
178
173
The New England Journal of Medicine 
Downloaded from nejm.org at RADBOUD UNIVERSITEIT NIJMEGEN on July 9, 2012. For personal use only. No other uses without permission. 
 Copyright © 2005 Massachusetts Medical Society. All rights reserved. 
 n engl j med 
 
352;23
 
www.nejm.org june 
 
9
 
, 
 
2005
 
The
 
 new england journal 
 
of
 
 medicine
 
2402
 
most three times the rate after open repair (hazard
ratio, 2.9; 95 percent confidence interval, 1.1 to
6.2; P=0.03). Thereafter, reintervention rates were
roughly parallel (hazard ratio, 1.1; 95 percent con-
fidence interval, 0.1 to 9.3; P=0.95).
We found that by the end of the first year after ran-
domization, the previously reported perioperative
survival advantage of endovascular aneurysm re-
pair over open repair was no longer apparent.
 
2
 
 Al-
though a lower rate of aneurysm-related death after
endovascular repair did appear to be maintained
during the first two years, in terms of overall surviv-
al, this was cancelled out by excess mortality from
other causes, including cardiovascular causes, in the
first two years after discharge.
One other randomized trial, the Endovascular
Aneurysm Repair (EVAR-1) trial, has compared the
results of endovascular aneurysm repair with those
of open repair.
 
1
 
 Whereas the early results of the
two trials were similar, the long-term results of
EVAR-1 are not yet available and thus cannot be
compared with our findings.
Our results are similar to those of two recently
reported retrospective, controlled studies compar-
ing endovascular and open repair.
 
9,10
 
 In both stud-
ies, the respective one-year survival rates after open
and endovascular repair were approximately 92 and
95 percent, and the respective two-year survival
rates were approximately 88 and 89 percent, all of
which are very close to our findings. The rates of
aneurysm-related death two years after open and
endovascular repair were 4.2 and 0.9 percent, re-
spectively, in the study by Cao et al.,
 
10
 
 as compared
discussion
 
* Two patients died before undergoing the assigned operation: one patient with preexistent pulmonary fibrosis assigned to undergo endovas-
cular repair died from pneumonia 84 days after randomization, and one patient assigned to undergo open repair died from a ruptured ab-
dominal aortic aneurysm.
† In-hospital data were reported previously.
 
2
 
 All 10 in-hospital deaths were aneurysm-related by definition. None of the nine deaths from car-
diovascular causes after discharge were aneurysm-related.
‡ The causes of death were as follows: infection of the prosthesis, anastomotic bleeding, ischemic bowel, intraoperative anaphylactic shock, 
multiorgan failure after repair of a burst abdomen, and progressive dementia and refusal to eat or drink leading to respiratory insufficiency 
and death.
§ The cause of death was bilateral pneumonia.
¶ The cause of death was peritonitis resulting from an iatrogenic bowel lesion during repeated operation to correct prosthetic malalignment.
¿ The cause of death was an infected endograft.
** The cause of death was pneumonia.
††The causes of death were as follows: peritonitis, pulmonary embolism, respiratory insufficiency, and general deterioration related to old age.
‡‡No data were available on the cause of death.
§§ Both patients died suddenly, 33 and 41 months after the procedure. A ruptured aneurysm was considered a possible cause of death, but in 
neither patient was a postmortem examination performed. Both patients had evidence of a shrinking aneurysm sac on their last (24-month) 
 
follow-up computed tomographic scan.
 
Table 2. Causes of Death after Open and Endovascular Repair of Abdominal Aortic Aneurysm.
Cause of Death Before Surgery* In the Hospital† After Discharge Overall
 
Open 
Repair
(N=178)
Endovascular
Repair
(N=173)
Open 
Repair
(N=174)
Endovascular
Repair
(N=171)
Open 
Repair
(N=166)
Endovascular
Repair
(N=169)
Open 
Repair
(N=178)
Endovascular
Repair
(N=173)
 
number of patients
 
All causes 1 1 8 2 9 17 18 20
Cardiovascular causes 0 0 2 1 3 6 5 7
Myocardial infarction 0 0 1 1 0 1 1 2
Cardiac arrest 0 0 1 0 2 2 3 2
Congestive heart failure 0 0 0 0 0 2 0 2
Stroke 0 0 0 0 1 1 1 1
Aneurysm-related, noncar-
diovascular causes
1 0 6‡ 1§ 1¶ 1¿ 8 2
Cancer 0 0 0 0 2 4 2 4
Other 0 1 0 0 1** 4†† 1 5
Unknown 0 0 0 0 2‡‡ 2§§ 2 2
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with 5.7 and 2.1 percent, respectively, in our study.
It is possible that the prospective nature of our
study allowed for more complete detection of
aneurysm-related deaths. The difference in reinter-
vention rates between the groups in our study is also
similar to that reported in both retrospective stud-
ies. In one study, the divergence of reintervention
rates did not start until after two years of follow-
up,
 
10
 
 whereas in our study, there was no significant
difference in reintervention rates beyond nine
months after randomization. This variation may
depend on how aggressively certain complications
are addressed.
Although our findings — and those in the other
trials discussed above — suggest that endovascular
aneurysm repair may provide an early survival ad-
vantage over conventional surgery, it appears that
this advantage is lost by the end of the first year. It
is unknown whether the durability of the endovas-
cular graft will jeopardize long-term outcomes. Al-
though nonrandomized, follow-up studies of pa-
tients who have undergone aneurysm repair have
failed to show a long-term advantage of open over
endovascular repair,
 
9,10
 
 concerns persist, since the
rates of aneurysm-related death and reintervention
after endovascular repair have been reported to con-
tinue to increase over time.
 
4,11
 
 The overall survival
curves in our trial appeared to converge in the sec-
ond year after randomization. Our 2-year data do
not exclude the possibility that these curves will ac-
tually cross, resulting in a higher rate of death for
endovascular repair than for open repair after 24
months.
There may be two possible explanations for the
convergence of survival curves in our study. One is
that patients who have survived the stress of open
repair may be somewhat less likely to die in the first
few months after surgery than patients who have
undergone endovascular repair, since the latter
group has not been subjected to a conventional
surgical procedure. In other words, the survival ad-
vantage resulting from a less-invasive approach to
aneurysm repair may largely be based on postpon-
ing death among higher-risk patients from the peri-
operative period to the subsequent months. Al-
though patients in our trial had to be eligible to
undergo conventional open aneurysm repair before
they could undergo randomization, the health of
patients with abdominal aortic aneurysms is often
seriously compromised by other types of cardiovas-
cular disease. In our study, 58 percent of the deaths
(22 of 38) were due to either cardiovascular causes
or causes related to aneurysm repair. This finding
is in accordance with those of other follow-up
studies of aneurysm repair.
 
12,13
 
Another possible explanation for the conver-
gence of survival curves is the failure of endovascu-
lar repair to prevent rupture of the aneurysm. How-
ever, endograft failure is unlikely to occur during
the first two years after implantation, and such fail-
 
Figure 2. Kaplan–Meier Estimates of Survival Free of Severe Events 
among Patients Assigned to Undergo Open or Endovascular Aneurysm Repair.
P=0.39
1.00
Pr
ob
ab
ili
ty
 o
f S
ur
vi
va
l
Fr
ee
 o
f S
ev
er
e 
Ev
en
ts 0.90
0.95
0.85
0.70
0.75
0.80
0
0 6 12 18 24
Endovascular repair
Open repair
Months after Randomization
No. at Risk
Open repair
Endovascular repair
89
91
121
125
146
151
150
155
178
173
 
Figure 3. Kaplan–Meier Estimates of Freedom from Reintervention 
among Patients Assigned to Undergo Open or Endovascular Aneurysm Repair.
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ure would be reflected by a convergence of the rates
of aneurysm-related death — an effect that was not
found in our analysis. Although a grouping of
deaths was seen in the endovascular-repair group
about one year after randomization, the causes of
death were not related to the aneurysm. Further-
more, the apparent grouping of these deaths was
seen in a Kaplan–Meier survival analysis that mea-
sured the time from randomization, rather than
the time from the procedure, indicating that this
grouping of deaths was not related to the course
after intervention. Only one patient in the endovas-
cular-repair group died of an aneurysm-related
cause (an infected endograft) after hospital dis-
charge. Whether the rate of graft failure will in-
crease with further follow-up remains to be seen.
In patients undergoing endovascular repair,
efforts should be made to maintain the survival ad-
vantage associated with avoiding conventional sur-
gery. This effort may at least in part be a matter of
strict risk-factor management. Beta-blockers, anti-
platelet agents, and statins were each being used in
less than 50 percent of our patients at baseline.
Clearly, less-than-optimal medication was used in
view of current guidelines on risk management for
patients with manifestations of atherosclerosis.
 
14-16
 
Of course, better perioperative and postoperative
management of risk factors could also improve the
results of open aneurysm repair.
In conclusion, the two-year results of the
DREAM trial indicate that the perioperative surviv-
al advantage with endovascular repair as compared
with open repair is limited to the first postopera-
tive year.
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